JP2010520223A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010520223A5 JP2010520223A5 JP2009551873A JP2009551873A JP2010520223A5 JP 2010520223 A5 JP2010520223 A5 JP 2010520223A5 JP 2009551873 A JP2009551873 A JP 2009551873A JP 2009551873 A JP2009551873 A JP 2009551873A JP 2010520223 A5 JP2010520223 A5 JP 2010520223A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- pyridyl
- pyridazine compound
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- -1 pyridazine compound Chemical class 0.000 claims description 30
- 239000008194 pharmaceutical composition Substances 0.000 claims description 23
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 15
- 125000001072 heteroaryl group Chemical group 0.000 claims description 13
- 229910052739 hydrogen Inorganic materials 0.000 claims description 12
- 239000001257 hydrogen Substances 0.000 claims description 12
- 125000000623 heterocyclic group Chemical group 0.000 claims description 11
- 206010010904 Convulsion Diseases 0.000 claims description 10
- 125000003545 alkoxy group Chemical group 0.000 claims description 10
- 125000000217 alkyl group Chemical group 0.000 claims description 10
- 125000003118 aryl group Chemical group 0.000 claims description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 10
- 125000001475 halogen functional group Chemical group 0.000 claims description 9
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims description 8
- CTQJAETYIVEEFX-UHFFFAOYSA-N [N-]=[N+]=NN(N)N=[N+]=[N-] Chemical compound [N-]=[N+]=NN(N)N=[N+]=[N-] CTQJAETYIVEEFX-UHFFFAOYSA-N 0.000 claims description 8
- 125000002252 acyl group Chemical group 0.000 claims description 8
- 125000004423 acyloxy group Chemical group 0.000 claims description 8
- 125000003342 alkenyl group Chemical group 0.000 claims description 8
- 125000004450 alkenylene group Chemical group 0.000 claims description 8
- 125000003302 alkenyloxy group Chemical group 0.000 claims description 8
- 125000002947 alkylene group Chemical group 0.000 claims description 8
- 125000000304 alkynyl group Chemical group 0.000 claims description 8
- 125000003435 aroyl group Chemical group 0.000 claims description 8
- 125000002102 aryl alkyloxo group Chemical group 0.000 claims description 8
- 125000004104 aryloxy group Chemical group 0.000 claims description 8
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 8
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 8
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 8
- 125000000392 cycloalkenyl group Chemical group 0.000 claims description 8
- 125000000000 cycloalkoxy group Chemical group 0.000 claims description 8
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 8
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 8
- 150000003839 salts Chemical class 0.000 claims description 8
- 125000004469 siloxy group Chemical group [SiH3]O* 0.000 claims description 8
- 125000005353 silylalkyl group Chemical group 0.000 claims description 8
- 125000004646 sulfenyl group Chemical group S(*)* 0.000 claims description 8
- 125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 claims description 8
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 claims description 8
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims description 8
- 150000003462 sulfoxides Chemical class 0.000 claims description 8
- 125000005309 thioalkoxy group Chemical group 0.000 claims description 8
- 125000004001 thioalkyl group Chemical group 0.000 claims description 8
- 125000005000 thioaryl group Chemical group 0.000 claims description 8
- 150000003573 thiols Chemical class 0.000 claims description 8
- 125000003808 silyl group Chemical group [H][Si]([H])([H])[*] 0.000 claims description 7
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 claims description 6
- 208000014526 Conduction disease Diseases 0.000 claims description 5
- 230000036461 convulsion Effects 0.000 claims description 5
- 125000004193 piperazinyl group Chemical group 0.000 claims description 4
- 125000004076 pyridyl group Chemical group 0.000 claims description 4
- 125000000714 pyrimidinyl group Chemical group 0.000 claims description 4
- 206010015037 epilepsy Diseases 0.000 claims description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 3
- 125000002098 pyridazinyl group Chemical group 0.000 claims description 3
- CBBGLQYNWJVHBM-UHFFFAOYSA-N (nitrocarbamoylamino)phosphonic acid Chemical compound C(=O)(N[N+](=O)[O-])NP(=O)(O)O CBBGLQYNWJVHBM-UHFFFAOYSA-N 0.000 claims description 2
- CSGQAXNJZHDONX-UHFFFAOYSA-N 4-methyl-6-phenyl-3-(4-pyrimidin-2-ylpiperazin-1-yl)pyridazine;dihydrochloride Chemical compound Cl.Cl.CC1=CC(C=2C=CC=CC=2)=NN=C1N(CC1)CCN1C1=NC=CC=N1 CSGQAXNJZHDONX-UHFFFAOYSA-N 0.000 claims description 2
- 239000003937 drug carrier Substances 0.000 claims description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 2
- 239000003981 vehicle Substances 0.000 claims description 2
- 150000002431 hydrogen Chemical class 0.000 claims 3
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims 2
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 claims 2
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 claims 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 2
- 125000002883 imidazolyl group Chemical group 0.000 claims 2
- 125000003373 pyrazinyl group Chemical group 0.000 claims 2
- 125000003226 pyrazolyl group Chemical group 0.000 claims 2
- 125000001422 pyrrolinyl group Chemical group 0.000 claims 2
- 125000000168 pyrrolyl group Chemical group 0.000 claims 2
- 125000003831 tetrazolyl group Chemical group 0.000 claims 2
- 125000001425 triazolyl group Chemical group 0.000 claims 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 150000004892 pyridazines Chemical class 0.000 claims 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 7
- 238000000034 method Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 3
- 230000002265 prevention Effects 0.000 description 2
- 125000003107 substituted aryl group Chemical group 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US90460607P | 2007-03-02 | 2007-03-02 | |
| US438507P | 2007-11-27 | 2007-11-27 | |
| PCT/US2008/055495 WO2008109437A2 (en) | 2007-03-02 | 2008-02-29 | Compositions and treatments for seizure-related disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010520223A JP2010520223A (ja) | 2010-06-10 |
| JP2010520223A5 true JP2010520223A5 (enExample) | 2012-03-29 |
Family
ID=39345468
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009551873A Pending JP2010520223A (ja) | 2007-03-02 | 2008-02-29 | 発作関連障害のための組成物および方法 |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP2131839A2 (enExample) |
| JP (1) | JP2010520223A (enExample) |
| AU (1) | AU2008223066A1 (enExample) |
| CA (1) | CA2679917A1 (enExample) |
| WO (1) | WO2008109437A2 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030176437A1 (en) | 2001-08-31 | 2003-09-18 | D.M. Watterson | Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death |
| MX2007005247A (es) | 2004-11-02 | 2008-03-13 | Univ Northwestern | Compuestos de piridazina, composiciones y metodos. |
| CA2589102C (en) | 2004-11-02 | 2013-08-13 | Northwestern University | Pyridazine compounds and methods for using the compounds to treat inflammatory diseases |
| AU2007243280A1 (en) | 2006-04-28 | 2007-11-08 | Northwestern University | Formulations containing pyridazine compounds for treating neuroinflammatory diseases |
| EP2015750A2 (en) | 2006-04-28 | 2009-01-21 | Northwestern University | Compositions and treatments using pyridazine compounds and cholinesterase inhibitors |
| AR072899A1 (es) | 2008-08-07 | 2010-09-29 | Merck Sharp & Dohme | Derivados de terpiridina-carboxamida antagonistas de receptores de orexina, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento del insomnio y la obesidad. |
| CN102272103B (zh) | 2008-10-30 | 2015-10-21 | 默沙东公司 | 异烟酰胺食欲素受体拮抗剂 |
| US8703770B2 (en) | 2008-10-30 | 2014-04-22 | Merck Sharp & Dohme Corp. | Pyridazine carboxamide orexin receptor antagonists |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2511366A1 (fr) * | 1981-08-11 | 1983-02-18 | Sanofi Sa | Nouveaux derives de la pyridazine, leur procede de preparation et les medicaments, actifs sur le systeme nerveux central, qui en contiennent |
| DE3217325A1 (de) * | 1982-05-08 | 1983-11-10 | Hoechst Ag, 6230 Frankfurt | 3-amino-6-aryl-1,2,4-triazolo(4,3-b)-pyridazine, ihre herstellung und ihre verwendung |
| US4654343A (en) * | 1985-10-31 | 1987-03-31 | American Cyanamid Company | N-substituted-N[3-(1,2,4-triazolo[4,3-b]pyridazin-6-yl)phenyl]alkanamides, carbamates and ureas |
| US20030176437A1 (en) * | 2001-08-31 | 2003-09-18 | D.M. Watterson | Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death |
| US20100168120A1 (en) * | 2006-04-28 | 2010-07-01 | Neuromedix Inc. | Salts of pyridazine compounds |
-
2008
- 2008-02-29 WO PCT/US2008/055495 patent/WO2008109437A2/en not_active Ceased
- 2008-02-29 CA CA002679917A patent/CA2679917A1/en not_active Abandoned
- 2008-02-29 AU AU2008223066A patent/AU2008223066A1/en not_active Abandoned
- 2008-02-29 EP EP08731122A patent/EP2131839A2/en not_active Withdrawn
- 2008-02-29 JP JP2009551873A patent/JP2010520223A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010520223A5 (enExample) | ||
| JP5367707B2 (ja) | Ｄｈｏｄｈ阻害剤としてのアザビフェニルアミノ安息香酸誘導体 | |
| JP2011529964A5 (enExample) | ||
| JP2013508288A5 (enExample) | ||
| JP2015508749A5 (enExample) | ||
| JP2006515858A5 (enExample) | ||
| JP2004521095A5 (enExample) | ||
| JP2008513504A5 (enExample) | ||
| US20210261542A1 (en) | Compounds which inhibit rna polymerase, compositions including such compounds, and their use | |
| CN1829708A (zh) | 哌啶化合物和含有它们的药物组合物 | |
| JP2007513093A (ja) | チューブリン阻害剤 | |
| JP2014518853A5 (enExample) | ||
| JP2013537203A5 (enExample) | ||
| JP2009526072A5 (enExample) | ||
| HRP20161011T1 (hr) | Aril dihidropiridinoni i piperidinoni kao inhibitori mgat2 | |
| RU2006126974A (ru) | Амидное производное и лекарственное средство | |
| JP2013544860A5 (enExample) | ||
| JP2016507575A5 (enExample) | ||
| JP2014532730A5 (ja) | オピオイド受容体の調節物質およびそれを含む薬学的組成物 | |
| MY148375A (en) | Delta and epsilon crystal forms of imatinib mesylate | |
| JP2015536997A5 (enExample) | ||
| JP2022017461A5 (enExample) | ||
| JP2018528273A5 (enExample) | ||
| JP2017508795A5 (enExample) | ||
| JP2014510147A5 (enExample) |